Small Dense Low-Density Lipoprotein Cholesterol and Carotid Intimal Medial Thickness Progression
- PMID: 32281547
- PMCID: PMC7585909
- DOI: 10.5551/jat.54130
Small Dense Low-Density Lipoprotein Cholesterol and Carotid Intimal Medial Thickness Progression
Abstract
Aim: The association between small dense low-density lipoprotein cholesterol (sdLDL-C) levels and carotid intimal medial thickness (cIMT) progression has not been evaluated fully. We assessed specialized lipoproteins, including sdLDL-C, with regard to cIMT progression in a prospective observational study in Japan.
Methods: Plasma total cholesterol, direct LDL-C, sdLDL-C, LDL-triglycerides (LDL-TG), high-density lipoprotein cholesterol (HDL-C), HDL2-C, HDL3-C, triglycerides, Lp(a), and adiponectin were measured in 2,030 men and women (median age 59 years, free of cardiovascular disease (CVD) and off cholesterol lowering medication). At both baseline and after a five-year follow-up, cIMT was assessed. Univariate, multivariate regression, and least square analyses were performed to examine the relationships between direct LDL-C, sdLDL-C, and other lipoproteins with cIMT progression.
Results: The median cIMT at baseline was 0.63 mm and five-year progression was 0.18 mm. After adjustment for standard CVD risk factors, including age, gender, systolic blood pressure, total cholesterol, HDL-C, smoking, diabetes, and hypertension treatment, only direct LDL-C, sdLDL-C, and the sdLDL-C/LDL-C ratio were associated with cIMT progression. Even in subjects with direct LDL-C <100 mg/dL, who were considered at low CVD risk, elevated sdLDL-C were associated with cIMT progression (P for trend=0.009) in a model with established CVD risk factors, although the sdLDL-C/LDL-C ratio did not. Those correlations did not change by including triglycerides as a controlling factor or excluding premenopausal women from the analyzed population.
Conclusions: Small dense LDL-C has a stronger relationship with cIMT progression than LDL-C does; therefore, measuring sdLDL-C may allow for the formulation of optimal therapy for CVD prevention.
Keywords: Atherosclerosis; Cardiovascular diseases; Carotid intimal medial thickness; Small dense LDL cholesterol.
Conflict of interest statement
The authors have nothing to declare with regard to conflict of interest.
Figures
![Supplementary Fig. 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7585909/bin/jat-27-1108-g003a.gif)
![Supplementary Fig. 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7585909/bin/jat-27-1108-g003a.gif)
![Supplementary Fig. 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7585909/bin/jat-27-1108-g003a.gif)
![Fig. 1.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7585909/bin/jat-27-1108-g001.gif)
![Fig. 2.](https://cdn.statically.io/img/www.ncbi.nlm.nih.gov/pmc/articles/instance/7585909/bin/jat-27-1108-g002.gif)
Similar articles
-
LDL-cholesterol to HDL-cholesterol ratio discordance with lipid parameters and carotid intima-media thickness: a cohort study in China.Lipids Health Dis. 2020 Jun 18;19(1):141. doi: 10.1186/s12944-020-01324-5. Lipids Health Dis. 2020. PMID: 32552893 Free PMC article.
-
[Small-Dense LDL, HDL2, 3].Rinsho Byori. 2016 Jun;64(6):636-642. Rinsho Byori. 2016. PMID: 30695317 Review. Japanese.
-
Associations between small dense LDL, HDL subfractions (HDL2, HDL3) and risk of atherosclerosis in Japanese-Americans.J Atheroscler Thromb. 2012;19(5):444-52. doi: 10.5551/jat.11445. Epub 2011 Dec 21. J Atheroscler Thromb. 2012. PMID: 22659528
-
Indicators of the atherogenic lipoprotein phenotype measured with density gradient ultracentrifugation predict changes in carotid intima-media thickness in men and women.Vasc Health Risk Manag. 2012;8:31-8. doi: 10.2147/VHRM.S27963. Epub 2012 Jan 16. Vasc Health Risk Manag. 2012. PMID: 22272073 Free PMC article.
-
High-density lipoprotein as a therapeutic target: a systematic review.JAMA. 2007 Aug 15;298(7):786-98. doi: 10.1001/jama.298.7.786. JAMA. 2007. PMID: 17699012 Review.
Cited by
-
An increase in calculated small dense low-density lipoprotein cholesterol predicts new onset of hypertension in a Japanese cohort.Hypertens Res. 2023 Dec;46(12):2635-2645. doi: 10.1038/s41440-023-01392-x. Epub 2023 Aug 2. Hypertens Res. 2023. PMID: 37532953
-
Prognostic Implication of Small Dense LDL-Cholesterol Levels following Acute Coronary Syndrome.Medicina (Kaunas). 2023 Jan 12;59(1):158. doi: 10.3390/medicina59010158. Medicina (Kaunas). 2023. PMID: 36676782 Free PMC article.
-
Diabetic dyslipidemia impairs coronary collateral formation: An update.Front Cardiovasc Med. 2022 Aug 22;9:956086. doi: 10.3389/fcvm.2022.956086. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36072863 Free PMC article. Review.
-
Small, Dense Low-Density Lipoprotein-Cholesterol and Atherosclerosis: Relationship and Therapeutic Strategies.Front Cardiovasc Med. 2022 Feb 10;8:804214. doi: 10.3389/fcvm.2021.804214. eCollection 2021. Front Cardiovasc Med. 2022. PMID: 35224026 Free PMC article. Review.
-
Kyushu and Okinawa Population Study (KOPS): a large prospective cohort study in Japan.BMJ Open. 2021 Dec 21;11(12):e053763. doi: 10.1136/bmjopen-2021-053763. BMJ Open. 2021. PMID: 34933862 Free PMC article.
References
-
- Global Health Estimates 2016: Deaths by Cause, Age, Sex, by Country and by Region, 2000–2016. Geneva, World Health Organization; 2018
-
- Goff DC, Jr, Lloyd-Jones DM, Bannett G, Coady S, D'Agostino RB, Sr, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC, Jr, Sorlie P, Stone NJ, Wilson PW, American College of Cardiology/American Heart Association Task Force on Practice Guidelines AHA/ACC guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol, 2014; 63: 2935-2959 - PMC - PubMed
-
- Lloyd-Jones DM, Morris PB, Ballantyne CM, Birtcher KK, Daly DD, Jr., DePalma SM, Minissian MB, Orringer CE, Smith SC., Jr. 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol, 2017; 70: 1785-1822 - PubMed
-
- Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18: 499-502 - PubMed